This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical
impact during cancer treatment among adult cancer patients≥ 18 years of age. A meta …

The adiposity influence on colorectal cancer prognosis remains poorly characterised. We
performed a systematic review and meta‐analysis on post‐diagnosis adiposity measures …

Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …

Study objective Determine if psoas muscle area measured in routine preoperative computed
tomography scans (CT) can be used to identify patients at increased risk of adverse …

Sarcopenia was initially described as a decrease in muscle mass associated with aging and
subsequently also as a consequence of underlying disease, including advanced …

Objective The prognostic value of the volume and density of skeletal muscles in the
abdominal waist of patients with colon cancer remains unclear. This study aimed to …

Background The impact of sarcopenia on the outcome of patients with left-sided colon and
rectal cancer has not been exhaustively investigated. Thus, the present study was performed …

Background Sarcopenia in cancer patients has been associated with mixed postoperative
outcomes. The aim of this study was to evaluate whether the development of sarcopenia …

SUMMARY OBJECTIVE: Colorectal cancer is the third most diagnosed malignant neoplasm
in the world and the fourth leading cause of cancer mortality. The loss of muscle mass in …

Background: Cholangiocarcinoma (CCA) represents the second most common primary liver
cancer and is characterized by a very poor outcome, but reliable prognostic markers are …